Cerus Corp (CERS)
1.80
-0.02
(-1.37%)
USD |
NASDAQ |
Sep 20, 16:00
1.80
0.00 (0.00%)
After-Hours: 20:00
Cerus Revenue (Quarterly): 45.08M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 45.08M |
March 31, 2024 | 38.36M |
December 31, 2023 | 46.77M |
September 30, 2023 | 39.77M |
June 30, 2023 | 38.85M |
March 31, 2023 | 30.97M |
December 31, 2022 | 44.03M |
September 30, 2022 | 39.57M |
June 30, 2022 | 41.00M |
March 31, 2022 | 37.44M |
December 31, 2021 | 39.86M |
September 30, 2021 | 36.13M |
June 30, 2021 | 31.48M |
March 31, 2021 | 23.38M |
December 31, 2020 | 28.20M |
September 30, 2020 | 23.61M |
June 30, 2020 | 21.50M |
March 31, 2020 | 18.61M |
December 31, 2019 | 20.92M |
September 30, 2019 | 18.02M |
June 30, 2019 | 18.21M |
March 31, 2019 | 17.50M |
December 31, 2018 | 16.52M |
September 30, 2018 | 15.40M |
June 30, 2018 | 15.42M |
Date | Value |
---|---|
March 31, 2018 | 13.56M |
December 31, 2017 | 16.24M |
September 30, 2017 | 10.80M |
June 30, 2017 | 9.525M |
March 31, 2017 | 7.006M |
December 31, 2016 | 10.12M |
September 30, 2016 | 10.18M |
June 30, 2016 | 9.251M |
March 31, 2016 | 7.632M |
December 31, 2015 | 9.656M |
September 30, 2015 | 8.045M |
June 30, 2015 | 8.83M |
March 31, 2015 | 7.692M |
December 31, 2014 | 9.587M |
September 30, 2014 | 10.36M |
June 30, 2014 | 8.601M |
March 31, 2014 | 7.866M |
December 31, 2013 | 9.232M |
September 30, 2013 | 10.54M |
June 30, 2013 | 10.15M |
March 31, 2013 | 9.733M |
December 31, 2012 | 10.53M |
September 30, 2012 | 8.252M |
June 30, 2012 | 9.224M |
March 31, 2012 | 8.691M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
18.02M
Minimum
Sep 2019
46.77M
Maximum
Dec 2023
33.18M
Average
36.79M
Median
Revenue (Quarterly) Benchmarks
Haemonetics Corp | 336.17M |
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | 6.029M |
Xtant Medical Holdings Inc | 29.94M |
Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -5.775M |
Total Expenses (Quarterly) | 48.92M |
EPS Diluted (Quarterly) | -0.03 |
Enterprise Value | 351.39M |
Gross Profit Margin (Quarterly) | 54.72% |
Profit Margin (Quarterly) | -12.81% |
Earnings Yield | -7.22% |
Normalized Earnings Yield | -6.724 |